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appears that perturbation of nucleo-cytoplasmic transport is an important event in these conditions but 
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TDP-43-expressing motor neurons before and after experimental initiation of cell death. We report the 
formation of mobile TDP-43 deposits within degenerating motor neurons, which are normally 
phagocytosed by microglia. However, when microglial cells were depleted, injury-induced motor neuron 
degeneration follows a characteristic process that includes TDP-43 redistribution into the cytoplasm, 
axon and extracellular space. This is the first demonstration of perturbed TDP-43 nucleocytoplasmic 
transport in vivo, and suggests that impairment in microglial phagocytosis of dying neurons may 
contribute towards the formation of pathological TDP-43 presentations in ALS and FTLD. 
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Abstract
Transactivating DNA-binding protein-43 (TDP-43) deposits represent a typical finding in almost all ALS patients, more 
than half of FTLD patients and patients with several other neurodegenerative disorders. It appears that perturbation of 
nucleo-cytoplasmic transport is an important event in these conditions but the mechanistic role and the fate of TDP-43 
during neuronal degeneration remain elusive. We have developed an experimental system for visualising the perturbed 
nucleocytoplasmic transport of neuronal TDP-43 at the single-cell level in vivo using zebrafish spinal cord. This approach 
enabled us to image TDP-43-expressing motor neurons before and after experimental initiation of cell death. We report the 
formation of mobile TDP-43 deposits within degenerating motor neurons, which are normally phagocytosed by microglia. 
However, when microglial cells were depleted, injury-induced motor neuron degeneration follows a characteristic process that 
includes TDP-43 redistribution into the cytoplasm, axon and extracellular space. This is the first demonstration of perturbed 
TDP-43 nucleocytoplasmic transport in vivo, and suggests that impairment in microglial phagocytosis of dying neurons may 
contribute towards the formation of pathological TDP-43 presentations in ALS and FTLD.
Keywords Amyotrophic lateral sclerosis (ALS) · Motor neuron disease (MND) · Neurodegeneration · Microglia · TDP-43 · 
Pathological spreading · Zebrafish
Introduction
Pathological deposition of protein aggregates characterises a 
large group of neurodegenerative diseases in which the key 
event is considered to be either the malformation of a key 
protein, or the failing of a crucial metabolic cascade, leading 
to the generation of a pathological proteinaceous agent that 
can self-propagate and result in gain- or loss-of-function 
progressing toward cell death [38].
An aggregating proteinopathy involving the TAR DNA-
binding protein (TDP-43) provides a molecular link between 
two progressive neurodegenerative diseases: amyotrophic 
lateral sclerosis (ALS) of the motor cortex, brainstem and 
spinal cord, and frontotemporal lobar degeneration (FTLD) 
of the frontal, insular, and temporal cortex (non-SOD1 ALS 
and non-tau FTLD, termed ALS-FTLD; [3, 13, 15, 22, 43]).
In biochemical and cell culture models, TDP-43 has been 
identified as spontaneously aggregation prone [1, 27]. This 
propensity has been localised to a low-complexity domain in 
the C-terminal region that may play a role in RNA binding, 
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granule formation, and/or liquid–liquid phase separation to 
subserve transcription dynamics and mRNA transport [6, 
12, 32, 34, 55, 56]. It is hypothesised that inherited or spon-
taneous mutation of the encoding gene, TARDBP, or of an 
interacting partner, upsets the balance between aggregation 
and dissolution of TDP-43 [14, 71], which may be differen-
tially regulated under changing conditions, including during 
the cellular stress/death response [7, 30].
TDP-43 also appears to display self-propagating behav-
iour. Feiler et al. [21] found that naive cultured mouse neu-
rons will internalise tagged, oligomerized TDP-43 from the 
culture medium of transfected neurons. This was mediated 
by the packaging of TDP-43 into microvesicles or exosomes, 
which were more effective at transmission than free protein. 
Linking this phenomenon to clinical observations, when cell 
culture models were seeded with phosphorylated TDP-43+ve 
insoluble fractions from ALS and FTLD patient brain or 
spinal cord, there was a significant increase in intracellular 
endogenous TDP-43 aggregation and subsequent cell death 
[44, 57]. To follow on from this we examined how motor 
neuron injury and subsequent degeneration mobilises TDP-
43 in vivo and may contribute to pathogenicity in ALS.
We have developed an in vivo transgenic model to visu-
alise subcellular compartments of individual motor neurons 
in zebrafish spinal cord. Using this new model, we have 
expressed fluorophore-tagged human TDP-43 within indi-
vidual spinal motor neurons to observe the intraneuronal 
localisation of TDP-43 over time. After confirming that the 
subcellular localisation of TDP-43 is the same in zebrafish 
and human, we discovered in vivo that TDP-43 concen-
trated in highly dynamic nuclear granules with droplet-like 
properties. By application of a cell-specific UV injury, we 
were able to induce neuronal degeneration, within which the 
fate of TDP-43 could be precisely followed. We found that 
motor neurons underwent a stereotyped neurodegenerative 
process with structural changes closely mirroring those of 
degenerating neurons in human tissue. We further report 
upon live-imaging evidence for different pathways of TDP-
43 release and distribution; as aggregated fragments, diffuse 
in cytoplasm, as a component of pyknotic or karryhorexic 
nuclear fragmentation, anterograde axonal diffusion or as a 
component of microglial uptake.
Materials and methods
Zebrafish care
Zebrafish (Danio rerio) were maintained under standard 
conditions [65]. Experiments were conducted under Mac-
quarie University Animal Ethics and Biosafety approv-
als (2012/050 and 2015/033; 5201401007). Larvae were 
raised in E3 medium at 28 °C on a 14:10 light:dark cycle. 
1-Phenyl-2-thiourea (PTU) was added to the E3 medium at 
24 hpf at 0.005% to inhibit pigmentation. All experiments 
in this study were conducted at 3–5 days post-fertilisation 
(dpf).
Transgenes
Tg(-3mnx1:kalTA4-4xnrUAS-E1b-H2B-mCerulean3-P2A-
mKO2-CAAX) (MQ13) was generated using recombined 
p5E-3mnx1 [40], pME: kalTA4-4xnrUAS-E1b, p3E-H2B-
mCerulean3-P2A-mKOFP2-CAAX [17], and pTol2pA2 
[33]. The pME:kalTA4-4xnrUAS-E1b construct was gen-
erated from PCR amplification of EcoRI- and Xho1-flanked 
kalTA4, and Xho1- and Sal1-flanked 4xnrUAS sequences 
from pME:kalTA4 and pME:4xnrUAS vectors, respec-
tively (both vectors were a kind gift from the Parton Lab, 
University of Queensland). A Sal1- and Spe1-flanked 
E1b minimal promoter was added to the 3ʹ end and the 
construct subcloned into a lab derived pDONR 221 (Inv-
itrogen) vector with EcoRI and Spe1 sites. The codon-
optimised H2B–mCerulean3–P2A–mKOFP2–CAAX 
sequence was ordered from GeneArt and recombined into 
pDONRP2R-P3 (Invitrogen) to create the p3E–H2B–mCe-
rulean3–P2A–mKOFP2–CAAX [17]. It incorporated a 
nuclear-localised mCerulean3 fluorophore and a membrane-
localised mKOFP2 (mKO2) fluorophore expressed in motor 
neurons.
Tg (-3mnx1:eGFP-HsaTDP-43WT) was generated using 
recombined p5E-3mnx1 (#74632) [40], pME-EGFP [33], 
p3E-HsaTDP-43 and pTol2pA2 [33]. The p3E-HsaTDP-43 
was generated by subcloning a BamHI–Spe1-flanked gene 
string encoding HsaTDP-43 (GeneArt) into the BamHI–Spe1 
sites of p3E-MCS (#75174) [17].
Transgenic lines were generated by co-injection of the 
Tol2-flanked constructs and transposase [28].
PU.1 (spi1b) morpholino
The PU.1 morpholino and a mismatch control used in this 
study were the same as those of Rhodes et al. [50], obtained 
from Gene Tools. Injections consisted of a 2 ng/nl concen-
tration of either active or mismatch morpholino in a 2-nl 
droplet calibrated by micrometre. Immediately after injec-
tions, dishes containing equal numbers of either active or 
mismatch injected larvae or uninjected siblings were coded 
by a third party and all following analyses were conducted 
blind to the injection condition. At 3 and 5 dpf, larvae were 
screened for developmental abnormalities and for the pres-
ence of any mCherry-CAAX fluorophore expression, indi-
cating the presence of mpeg1 expressing monocytes.
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PU.1 (spi1b)-targeted active MO: 5ʹ-GAT ATA CTG ATA 
CTC CAT TGG TGG T-3ʹ
PU.1 (spi1b) mismatch MO: 5ʹ-GAT AAA CTG TTA CTC 
GAT TGC TGG T-3ʹ
Notes on morpholino and zebrafish PU.1 
orthologues spi1a/b
An in silico analysis showed that for the two zebrafish ortho-
logues of PU.1, spi1a and spi1b, the morpholino above 
contains a matching sequence only for spi1b (D. rerio, 
GRCz10). Given the efficacy of the morpholino in this and 
previous studies [25, 48–50] knockdown of spi1b appears 
sufficient to induce primitive monocyte lineage inhibition 
in the zebrafish.
Imaging and UV injury induction
Imaging was conducted on a Leica SP5 confocal microscope. 
mTagBFP was excited by 405-nm laser diode, which was 
also used at higher power to induce UV injury [41]. eGFP 
was excited by an argon laser at 488 nm. mKO2-CAAX and 
mCherry-CAAX were excited by a Leica white-light laser at 
552 and 587 nm, respectively. Imaging for Fig. 2 and Online 
Resources 1 and 6 was conducted with an 8 kHz Leica reso-
nance scanner. Objectives used were a Leica 40x HCX APO 
L U-V-I water immersion and a Leica 63X HC APO U-V-I 
CS2 water immersion.
Imaging processing was conducted in ImageJ (1.51n). 
Deconvolution was applied for Figs. 1, 2, 4, 5, 6 and 7. Point 
spread functions were generated by the Richards and Wolf 
algorithm [51] as implemented in the PSF generator plugin 
for ImageJ [31]. Richardson–Lucy deconvolution was car-
ried out in the DeconvolutionLab plugin for ImageJ [53]. A 
mean filter of radius 1 was applied to Figs. 4 and 6.
3D volume analysis of TDP‑43 nuclear/cytoplasm 
ratio
The ratio of nuclear to cytoplasmic eGFP-TDP43WT over the 
3D neuron volume was derived by first establishing a separa-
tion of voxels containing eGFP-TDP43WT alone (cytoplasm) 
or both eGFP-TDP43WT and H2B-mCerulean3 (nucleus) 
using a custom macro in ImageJ. Fluorescence grey value 
of each voxel was regarded as an indication of fluorophore 
concentration and the voxel grey value was summed over 
each set. The neurons used in this analysis were imaged from 
the same crossing and with identical microscope excitation 
and collection settings.
3D volume analysis of TDP‑43 accumulations
The volume measurements of the nuclear accumulations 
of eGFP-TDP43WT were derived by automatic 3D object 
recognition in ImageJ. 205-µm × 51-µm × 24-µm z-stacks 
were acquired in the spinal cord of three larvae express-
ing mnx1-driven eGFP-TDP43WT from the same crossing. 
Object counting was conducted with the Object Counter3D 
plugin in ImageJ (plugin authors are F. Cordelières and J. 
Jackson. The plugin is available at http://rsbwe b.nih.gov/ij/
plugi ns/track /objec ts.html).
Axonal eGFP localisation
For the analysis of eGFP in the axon before and after UV 
injury of Fig. 7 and Online Resource 9, the Simple Neurite 
Tracer plugin for ImageJ (v3.1.3, [36]) was used to generate 
a neurite vector and gather individual segment and whole 
neurite fluorescence intensity measures.
For the baseline of eGFP signal present in uninjured 
motor neuron axons of Supplementary Figure 4 (Online 
Resource 10), an 8-µm segmented line was drawn along the 
axon path from the hillock in Z-projected stacks, as visu-
alised by the mKO2-CAAX fluorophore. The mean grey 
value was measured in the voxels falling on this line for 
both mKO2-CAAX and eGFP. To demonstrate that any 
eGFP signal was not lost to a process of background sub-
traction, we sampled two 8-µm lines in regions of the same 
image without a positively expressing cell to determine the 
background levels for each fluorophore in each image. These 
background values were averaged and reported to give the 
background value used for comparison to the axon path. The 
neurons used in this analysis were imaged from the same 
crossing and with identical microscope excitation and col-
lection settings.
Statistical analysis
The software R (3.3.2) was used for statistical analyses. Dif-
ferences between the means were evaluated using ANOVAs 
and post hoc Tukey tests. For all statistical tests, significance 
was taken as P < 0.05. Unless otherwise indicated, data val-
ues are presented as the mean ± standard error of the mean 
(SEM). Graphs were generated in R (3.3.2) and Microsoft 
Excel 2016.
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Results
Visualising the distribution of TDP‑43 within spinal 
motor neurons using sub‑compartment‑specific 
reporters
To visualise and temporally monitor the process of motor 
neuron degeneration and the subsequent fate of intraneuronal 
TDP-43 in the living spinal cord, we developed a multi-
transgenic approach in zebrafish. Expression of fluorophore 
reporters was driven by the mnx1 promoter, previously 
described in primary motor neurons and interneurons in the 
zebrafish spinal cord [40, 42, 68]. Fluorophores were tar-
geted towards specific subcellular compartments through the 
use of specific peptide tags, for membrane (mKO2-CAAX), 
nucleus (H2B-mCerulean3) and cytoplasm (mTagBFP) 
(Figs. 1, 2). Human wildtype TDP-43 (TDP-43WT) was 
visualised with an eGFP tag (eGFP-TDP43WT, Fig. 1biv).
In the motor neurons of the zebrafish spinal cord, eGFP-
TDP43WT was observed to be strongly concentrated in the 
nucleus while relatively diffuse in the cytosol (Figs. 1biv, 2). 
This is in keeping with qualitative observations in human 
tissue section [43, 61], mouse tissue [39, 54] and cell culture 
models [4, 64]. To quantify this distribution, we assayed the 
relative distribution of eGFP-TDP43WT across the nucleus 
and cytoplasm over the entire cell body as a 3D volume, as 
determined by comparison with the co-expressed nuclear 
marker, H2B-mCerulean3 (see “Materials and methods”). 
We found that 78.2% of eGFP-TDP43WT localised to the 
nucleus (± 4.6%, n = 12 neurons in 4 larvae). This percent-
age is in line with a ~ 85% nuclear localisation reported 
previously using western blot quantitation of nuclear/cyto-
plasmic fractions from cultured hippocampal neurons [64].
Visualisation of dynamic TDP‑43 granula 
in the nucleus of spinal motor neurons
The nucleus contained eGFP-TDP43WT in the form of 
discrete fluorescent “granula”. Automatic 3D object 
analysis of the TDP-43 aggregates revealed a volume 
range of 0.023–5.7  µm3, with 83% falling in the range 
of 0.023–0.048 µm3 (132 accumulations in three larvae, 
Supplementary Fig. 1 (Online Resource 10)). Live imag-
ing revealed that these TDP-43 granula were not station-
ary but showed highly dynamic movements within the 
nucleus (Online Resource 1). Using high-frequency image 
acquisition (8 kHz resonance scanner, image every 50 s), 
droplet-like interactions between the accumulations could 
be observed (Fig. 2 and Online Resource 1). These may be 
indicative of TDP-43 incorporation in nuclear phase-sepa-
ration compartmentalisation [60, 70].
Fig. 1  Fluorescent primary motor neurons in the zebrafish spinal 
cord at 3 dpf. a Maximum intensity projection of a z-stack of a motor 
neuron revealing the complete axonal arbour (yellow) projecting into 
and around the myotome (not shown). At the cell body the spindly 
dendritic arbour can also be observed. The nucleus is visualised in 
mCerulean3 (cyan). Traversing the image is the axon of a spinal 
interneuron. Scale  =  10  µm. b A separate fluorescent motor neu-
ron (bi), demonstrating the mnx1-driven membrane-bound mKO2-
CAAX (yellow, bii), nuclear H2B-mCerulean3 (cyan, biii) and 
 HsaTDP43WT-linked eGFP (green, biv). Scale = 2 µm
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Targeted UV‑mediated injury in motor 
neurons induced a local microglial response 
including phagocytosis of intracellular TDP‑43
We have previously demonstrated that application of a UV 
laser (405 nm) can selectively induce injury and cell death 
in zebrafish motor neurons in vivo [40, 41]. The UV laser 
beam can be focused to a narrow column of subcellular 
width. Accordingly, as shown in experiments with spi-
nal cord motor neurons expressing the photoconvertible 
Kaede fluorophore, a single motor neuron can be precisely 
targeted [40]. To further characterise the UV-mediated 
cellular damage in this in vivo model, we examined the 
bleaching curves in the regions immediately neighbour-
ing the laser beam. Bleaching did occur around the target 
column; however, it was attenuated by 50% within 10 µm 
(approx. one cell width) and nearly 80% within 20 µm 
[Supplementary Fig. 2 (Online Resource 10)]. This steep 
power attenuation in the immediate surroundings of the 
laser beam supports the view that our method can be used 
to inflict very precise subcellular damage to selectively 
induce degeneration of a TDP-43-expressing neuron with-
out inducing any significant injury to surrounding cells.
To examine the response of spinal microglia to the 
degeneration of a single spinal motor neuron, we generated 
transgenic fish that co-express cytoplasmic mTagBFP in 
motor neurons [17] and mCherry-CAAX in macrophages/
microglia (mpeg1.1 promoter, [18]), respectively. Using 
DNA injections of eGFP-TDP43WT into these larvae we 
achieved expression of tagged TDP-43 in individual spinal 
motor neurons that allowed precise visualisation of TDP-
43 distribution after laser ablation (n = 7 motor neurons 
in 6 larvae).
Following targeted injury, individual spinal microglia 
could be observed to approach the injured neuron either 
to phagocytose the cell soma (n = 3; Fig. 3 and Online 
Resource 2) or to establish contact without phagocyto-
sis (n = 3; Online Resource 3; one other neuron showed 
no morphology change or microglia response within a 
6 h imaging period). The microglia response was swift 
and occurred within 1–2  h post-injury. The response 
was directed as the microglia cell body moved towards 
the injury site and extended cell processes towards the 
target membrane. We have previously characterised and 
quantified this phagocytic behaviour in more detail [40]. 
Overall we confirmed that UV-induced neuron degenera-
tion triggers a local microglia response while sub-lethal 
stress results in a transient microglia interaction (Online 
Resource 3).
In three experiments in which we observed microglia 
phagocytosis of targeted neurons, the microglia ingested 
TDP-43 as part of their phagocytic response. Visualis-
ing the localisation of eGFP-TDP43WT during this process 
showed that during laser-induced neuronal degeneration 
Fig. 2  Nuclear TDP-43 accumulations are highly motile. Fast reso-
nance scan of a motor neuron cell body with cytoplasmic mTagBFP 
(magenta) and nuclear eGFP-TDP43WT (green) revealed that these 
TDP-43 accumulations rapidly dissociate and coalesce. The full time-
lapse video gives the best example of the TDP-43 motility (Online 
Resource 1). Arrows indicate and follow distinct accumulations over 
the imaging period. Scale = 1 µm
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Fig. 3  Microglial uptake of TDP-43. Sequence of a spinal microglia (mCherry-CAAX, red) migrating toward and engulfing an eGFP-TDP43WT 
(green)-expressing motor neuron during UV-induced degeneration. Scale = 10 µm
Fig. 4  Expansion and dissolution of a motor neuron over the course 
of UV-induced degeneration in the absence of microglia. ai Cyto-
plasmic mTagBFP signal pre-irradiation. aii–iv Cytoplasmic changes 
during UV-induced degeneration. bi eGFP-TDP43WT distribution in 
the soma of the neuron pre-irradiation. bii–iv eGFP-TDP43WT mis-
localises into the cytoplasm during degeneration. c Merged images. 
Scale = 2 µm
451Acta Neuropathologica (2018) 136:445–459 
1 3
microglia internalised TDP-43 predominantly as a com-
ponent of the neuron nucleus. The fluorescence was 
lost rapidly (between frames, < 4 min) in the microglial 
phagosome, likely due to lysosomal fusion and rapid 
acidification of the organelle [48]. This is reminiscent of 
the finding in the zebrafish tectum that microglia phago-
cytosis occurs early in the cell death process, usually pre-
ceding the binding of extracellular AnnexinV [48, 62] and 
Fig. 5  Blebbing and TDP-43 mislocalisation in a motor neuron over 
the course of UV-induced degeneration after depletion of microglia. 
ai Cytoplasmic mTagBFP signal pre-irradiation. aii eGFP-TDP43WT 
distribution in the soma of the neuron pre-irradiation. aiii Merged 
images. bi–iv eGFP-TDP43WT signal redistributes into the cyto-
plasm and shows the blebbing of the cell soma during degenera-
tion. Note the apparent fragmentation of the nucleus, in contrast to 
the concentration of nuclear eGFP-TDP43WT in the previous figure. 
Scale = 2 µm
Fig. 6  Fragment release from a neuron undergoing UV-induced 
degeneration in the absence of functional microglia. ai Cytoplasmic 
mTagBFP signal pre-irradiation. aii eGFP-TDP43WT distribution in 
the soma pre-irradiation. aiii Merged images. bi–vi mTagBFP during 
UV-induced degeneration. Concentrated fragments can be observed 
separating from the external membrane before the cytoplasm dis-
perses. ci–vi eGFP-TDP43WT during degeneration. Concentrated 
fragments can be observed collecting and releasing from the mem-
brane. The concentrated (pyknotic) nuclear core gradually fragments. 
Scale = 2 µm
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Fig. 7  Axonal redistribution of eGFP-TDP43WT during UV-induced 
degeneration and microglia depletion. a Pre-irradiation, line is a pro-
jection of the axon vector used for signal analysis. Scale = 5 µm. bi–
iv At each time point from left to right the three windows represents 
a single time point illustrating the cell body and the TDP-43 distri-
bution (soma, eGFP-TDP43WT in green), the axonal projection (axon, 
mTagBFP in magenta incl. neurite vector as yellow line), and the flu-
orescence intensity of eGFP in the segments along the neurite vector. 
c Line graph demonstrating the time course of the mean eGFP fluo-
rescence intensity along the axon post-stress induction. Scale = 2 µm. 
Note: axonal redistribution was observed in 2 of the 10 neurons, 
which were targeted for UV injury and underwent degeneration
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suggests that microglia play an important role in phago-
cytosing degenerating motor neurons and intraneuronal 
TDP-43.
Depletion of microglia revealed the sequence 
of neurodegeneration and TDP‑43 redistribution
To fully elucidate the fate of TDP-43 in a dying motor neu-
ron in vivo, we inhibited microglial phagocytosis by mor-
pholino targeting of PU.1 (zebrafish spi1b, see “Materials 
and methods”). PU.1 is a well-characterised transcription 
factor and essential for monocyte to macrophage lineage 
progression, and knockdown of PU.1 has been shown to reli-
ably cause macrophage deficiency in zebrafish [25, 48–50].
Larvae were injected with a PU.1-targeted morpholino 
or a 4-bp-mismatch control and screened for effective mac-
rophage knockdown as well as common morpholino-associ-
ated developmental abnormalities [5]. Specific morpholino-
induced abnormalities were not observed [Supplementary 
Fig. 3a (Online Resource 10)] and macrophage knockdown 
was confirmed at 72 h post-fertilisation (hpf) [Supplemen-
tary Fig. 3b (Online Resource 10)]. Repopulation of mac-
rophages in these knockdown larvae had begun at 120 hpf.
Within the 72–120-hpf time window, spinal cord motor 
neurons were injured with the laser as described (n = 14 
cells in 12 larvae). In the absence of the primary mac-
rophages, targeted motor neurons underwent a consistent 
process of degeneration. Following injury, the motor neuron 
cell bodies showed swelling (n = 10 of 14, Figs. 4, 5). At its 
maximum, the cell became spherical in shape (Figs. 4ciii, 
5biv, 6ci, 7biv). The time taken to reach this full expansion 
was variable (22 min to 5 h 26 min). However, within min-
utes of reaching this morphology, all neurons rapidly shrunk 
and lost the majority of the cytoplasmic fluorescent signal 
as it became dispersed to the extracellular space (Online 
Resources 4 and 5).
Importantly, during the phase of cellular expansion, 
eGFP-TDP43WT rapidly redistributed from the nucleus to the 
cytoplasm (Figs. 4b, 5b). This process was confirmed using 
high-frequency image acquisition (8 kHz resonance scan-
ner sequence, Online Resource 6). The nucleus remained 
visible as the brightest accumulation of eGFP-TDP43WT in 
either a condensed form (pyknotic) (Fig. 4biii) or it became 
fragmented (karyorrhexic) (Fig. 5 bii–iv). In the case of 
pyknosis, the remaining core of nuclear eGFP-TDP43WT 
persisted initially and disintegrated slowly thereafter (see 
next section).
TDP‑43 fragments are released by dying motor 
neurons
Prior to the expansion and dissolution of the degenerating 
neuron, and in the absence of phagocytosing microglia, 
we occasionally observed fluorescently tagged fragments 
moving from the cytoplasm into the extracellular space. As 
shown in Fig. 6 and Online Resource 7, these fragments 
occasionally contained eGFP-TDP43WT. After expansion 
and dissolution, and after the nucleus had assumed a pyk-
notic morphology, the remaining core of eGFP-TDP43WT 
could be observed to gradually fragment and disperse 
(Fig. 6cvi and best illustrated live in Online Resource 7).
Axonal mislocalisation of TDP‑43 prior to cellular 
disintegration
In addition to morphological alterations of the cell body, we 
also observed beading and disintegration of the axon as a 
sequela of UV-induced degeneration of spinal motor neurons 
(Online Resource 8). To follow up on this, we investigated 
whether the mislocalisation of TDP-43 into the cytoplasm 
was accompanied by an increase in axonal TDP-43. To 
establish a baseline, we examined eGFP-TDP43WT distri-
bution in the axons of uninjured neurons in mKO2-CAAX 
co-expressing larvae. eGFP-TDP43WT was not detected 
along the axon proximal to the cell body [n = 8 neurons in 
three larvae, Supplementary Fig. 4 (Online Resource 10)]. 
Similarly, for the motor neurons targeted by UV to induce 
degeneration, such as the neuron demonstrated in Fig. 7, no 
eGFP-TDP43WT was detectable along the motor axon from 
the hillock to its conjunction with the axon bundle leading 
down into the myotome, whereas mTagBFP was present 
throughout the cytoplasm and along the axon. However, in 
two of the ten motor neurons that underwent UV-induced 
degeneration, we observed that the process of cellular 
expansion was accompanied by a rapid movement of eGFP-
TDP43WT into the axon. The process is illustrated in Fig. 7 
and Online Resource 9, both visually and by plotting the 
eGFP fluorescence intensity along the 3D traced axon over 
time. Following injury, the mean eGFP-TDP43WT intensity 
along the axon increased during the process of degenera-
tion before spiking rapidly ~ 5 h after the initial UV stress 
(but prior to dissolution as described above). The observa-
tion of inducible spreading of TDP-43 into axons in a living 
organism points to the existence of a potential molecular 
mechanism for progressive transmission and redistribution 
of pathological TDP-43 to neighbouring and distal neurons 
within the motor system.
Discussion
Our understanding of the molecular pathogenesis of ALS 
and FTLD is limited by our incomplete understanding of 
the sequence of events underpinning the pathology. Many 
of the insights we currently have on the hallmarks of ALS/
FTLD were derived from postmortem histological studies. 
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In almost all ALS patients and more than half of FTLD 
patients, the key molecular histopathological hallmark is the 
presence of abnormal amounts of intracellularly deposited 
TDP-43. It typically forms cytoplasmic-insoluble aggregates 
within neurons [3, 43]. Numerous in vitro models of TDP-
43 overexpression (wildtype and mutant) have been inves-
tigated to understand how these TDP-43 aggregates are 
formed. These studies collectively suggest that TDP-43 is a 
Fig. 8  Illustration of the proposed in  vivo process of stress-induced 
degeneration of a neuron in the zebrafish spinal cord. a An unin-
jured spinal motor neuron expressing fluorescent TDP-43 (green) 
predominantly in the nucleus. Insert depicts the measured distribu-
tion of TDP-43 between the cytoplasmic and nuclear compartments 
in the cell soma volume with ~ 80% TDP-43 localised in the nucleus 
(dotted line) and ~ 20% localised in the cytoplasm. b In the presence 
of microglia (red), the stressed/injured neuron is rapidly recognised 
and phagocytosed by the microglial cell. TDP-43 is taken up and con-
tained during this process. c In the absence of microglia, the stressed/
injured neuron undergoes a characteristic sequence of neurodegenera-
tion and TDP-43 redistribution (I–II). Individual stages of this pro-
cess have been described previously in clinical literature and are cited 
below (note that the continuous sequence of events has so far not 
been demonstrated in  vivo). The cell soma shows dysmorphia with 
a distinctive swelling (dotted line, resembling expansion or “balloon-
ing” observed across neurodegenerative histology: AD and CJD [16], 
SMA [37], HD [52], TDP-43 mislocalisation into the cytoplasm [23] 
and nuclear condensation [24]). At the end stage of this process TDP-
43 is redistributed along the axonal projections into the distal parts of 
the neuron [9–11]. d The degenerated neuron loses its integrity ini-
tially in the cell soma and shows characteristic blebbing of the degen-
erating axonal projections. Conceivably, the lack of neuroprotective 
microglia allows the spread of TDP-43 aggregates into the neuropil 
and extracellular tissue
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highly aggregation-prone protein [27] and that a variety of 
molecular pathways can lead to cytoplasmic mislocalisation, 
aggregation and inclusion formation [14, 20, 30, 56, 71]. 
Moreover, although a true phenocopy of ALS/FTLD has 
been elusive in TDP-43 animal models [26], the overexpres-
sion of mutant forms of TDP-43 in mice does result in the 
development of motor impairment and lethality [29, 58, 63]. 
A key challenge with these animal models is that similar to 
the clinical postmortem situation, the disease histopathol-
ogy only provides snapshots at different time points during 
disease progression. In contrast, in the present study, we 
were able to observe the fate and dynamics of TDP-43 cyto-
plasmic deposition in real-time at high resolution within the 
spinal cord in vivo. Notably, we were able to identify distinct 
stages of motor neuron degeneration and the mislocalisation 
and spread of TDP-43. In Fig. 8, we summarise the tempo-
ral sequence of neurodegeneration and TDP-43 mislocalisa-
tion. While this process of UV-mediated injury can reflect 
an accelerated cell-death pathway, we occasionally observed 
the formation of TDP-43 aggregates in the cytoplasm of spi-
nal motor neurons. It will be important to explore if these 
aggregates are of similar structure and function to the patho-
logical aggregates (e.g. phosphorylation status of TDP-43) 
that are observed in diseased human postmortem tissue and 
in animal models overexpressing mutant TDP-43.
The subcellular redistribution of TDP-43 from the 
nucleus to the cytoplasm in injured motor neurons (when 
microglia were depleted and, therefore, the cells were not 
rapidly phagocytosed) was especially striking, and this study 
represents the first real-time in vivo observation of the phe-
nomenon. This redistribution of TDP-43 to the cytoplasm 
has been suggested to represent a landmark feature of the 
onset and progression of ALS/FTLD [23, 43], and in cell 
culture the disrupted trafficking of TDP-43 is a precursor 
to the formation of cytoplasmic TDP-43 inclusions [66]. 
Previously, Sato et al., [54] have reported the cytoplasmic 
mislocalisation of TDP-43 in response to neuronal stress in 
a mouse ligation model. Our observations provide in vivo 
support for the hypothesis that cytoplasmic accumulation 
of TDP-43 in motor neurons could occur as a direct down-
stream consequence of neuronal stress or injury. It is impor-
tant to point out that in our experiments microglia did not 
directly prevent the cytoplasmic mislocalisation of TDP-43 
in UV-injured motor neurons, rather this process was cir-
cumvented by the microglial phagocytosis of the degener-
ating neuron. This raises an intriguing question—why is 
TDP-43 pathology limited to ALS/FTLD and not other neu-
rodegenerative diseases (such as Alzheimer’s, Parkinson’s 
and Huntington diseases)? It is possible that the TDP-43 
redistribution that we have observed is elicited by specific 
types of neuronal stress/injury (such as UV that was used 
in this study). Alternatively, it is possible that microglia are 
specifically defective in their phagocytic function in ALS/
FTLD (and not other diseases), therefore, allowing intracel-
lular TDP-43 redistribution to occur. These are important 
directions for future follow-up. Interestingly, Spiller and 
colleagues recently demonstrated the selective uptake of 
TDP-43 by reactive microglia in mice, and that this process 
is likely to play an important role in clearing pathological 
(mislocalised) TDP-43 from neurons [59].
Significant recent interest in the field has focussed on 
the potential cell-to-cell transfer of TDP-43 and/or associ-
ated proteins, and the possibility that this might facilitate 
propagation of the disease process through the motor system. 
In vitro, the intercellular transfer of TDP-43 has been dem-
onstrated [21, 47, 57, 67]. However, whether this also occurs 
in vivo remains an open question. In our study, we observed 
two pathways for transfer of TDP-43 from the originating 
dying neuron: uptake by microglia via direct phagocytosis 
and transfer into the surrounding neuropil.
UV injury-induced degeneration resulted in a phagocytic 
response by spinal microglia, which took up predominantly 
nuclear TDP-43. This represents the first in vivo demonstra-
tion of TDP-43 uptake by microglia as well as the prevention 
of TDP-43 spreading by normal microglia. Further study 
into the fate of TDP-43 and whether microglial function 
is altered following TDP-43 uptake in the zebrafish model 
may help expand upon the early evidence for microglial 
involvement in the progression of ALS/FTLD [8, 35, 46]. 
For example, phagocytosis of degradation-resistant TDP-
43 aggregates [69] may disrupt the lysosomal pathway in 
microglia and, therefore, impair their ability for clearance 
of TDP-43. Interestingly, Paolicelli et  al. have recently 
reported that TDP-43 depletion in Cx3Cr1-expressing cells 
(including microglia) led to an increase of phagocytosis and 
elevated transcription of lysosomal components [46]. This 
suggests that both endogenous and exogenously acquired 
TDP-43 may alter the functional behaviour of microglia, and 
contribute towards the progression of ALS/FTLD.
Depletion of microglia through PU.1 knockdown 
allowed us to visualise intracellular spreading of TDP-
43. In fact, we observed at least three pathways for TDP-
43 dispersal following motor neuron degeneration after 
injury: this included diffusion of TDP-43 from the nucleus 
to the cytoplasm after neuronal swelling, compartmental-
ised TDP-43 release in discrete quanta, and the break-
down of homeostatic TDP-43 exclusion from the axon. 
Concerning the interesting axonal spreading of TDP-43 
it is important to note that we consistently did not detect 
any eGFP-TDP43WT inside axons of healthy spinal motor 
neurons. Neuronal cell cultures and drosophila imaging 
have identified axonal TDP-43 as a component of transport 
vesicles in keeping with a role as a chaperone of RNA 
transport [2, 19]. We frequently observed the cytoplasmic 
mTagBFP and the CAAX-tagged membrane-bound mKO2 
fluorophores incorporated into transport vesicles moving 
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antero- as well as retro-grade along the axon (data not 
shown). However, we never observed this active transport 
for eGFP-TDP43WT. This difference indicates the intrigu-
ing possibility that the incorporation of TDP-43 into 
transport vesicles may be differentially regulated between 
neuronal cell types, in an in vivo setting (i.e. cell culture 
vs vertebrate spinal cord) or in distinct environmental or 
developmental contexts.
This study provides the first live-imaging data to sup-
port axonal-mediated spreading of TDP-43 [9, 45]. In 
combination with observations obtained in cell cultures 
suggesting TDP-43 transfer via the axonal membrane [21], 
this provides evidence that axonal TDP-43 might be an 
important mediator of ALS/FTLD pathology. It is worth 
noting that alongside our observations of spinal microglia 
engulfment of motor neuron cell bodies in this study and 
in two previous studies [40, 41], we have never observed 
microglial phagocytosis of degenerating axons. Given 
that microglial neuronophagia preceded TDP-43 nucleo-
cytoplasmic transport and that the anterograde movement 
of TDP-43 was a late process in neuron degeneration (that 
we could observe best when microglia were depleted), it is 
reasonable to conclude that rapid microglial phagocytosis 
of injured motor neuron somata is an effective mechanism 
for the prevention of TDP-43 spread.
Taken together, nucleo-cytoplasmic transport of TDP-
43 was studied in real time in the living spinal cord, and 
revealed that depletion of functional microglia leads to 
axonal and extracellular spreading of the pathological pro-
tein. This provides new insight into the potential direct 
role of microglia as well as pathways for protein distribu-
tion in the cascade of cellular and molecular events that 
cause ALS and FTLD.
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